Patent · US Active

Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome

US8748483B2 · kind B2 · utility

0Cited by

7References

5Claims

0Family size

Assignee

Sanofi · FR

Inventors

Harm Brummerhop · Scheinfeld, DE
Siegfried Stengelin · Frankfurt am Main, DE
Hubert Heuer · Frankfurt am Main, DE
Susanne Kilp · Hergenfeld, DE
Andreas Herling · Bad Camberg, DE
Thomas Klabunde · Frankfurt, DE
Dieter Kadereit · Kelkheim, DE
Matthias Urmann · Eschborn, DE

Key dates

Filing date	Jul 16, 2009
Grant date	Jun 10, 2014
Priority date	—
Expiry date	Jun 12, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of substituted pyranone acid derivatives and of their physiologically acceptable salts for producing medicaments for treating the metabolic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.